医学信息2023，Vol.36Issue(23)：170-173,183,5.DOI:10.3969/j.issn.1006-1959.2023.23.043
子痫前期的药物预防研究
Research on Drug Prevention of Preeclampsia
郭丽 1黄淑娟 1隋红梅1
作者信息
- 1. 天津中医药大学附属北辰中医院产科,天津 300400
- 折叠
摘要
Abstract
Preeclampsia is a common clinical complication of pregnancy.Clinical patients are mostly after 20 weeks of pregnancy,mainly manifested as elevated blood pressure,proteinuria,headache,blurred vision,upper abdominal pain,oliguria and other symptoms.The pathogenesis of preeclampsia is complex,and the clinical is not yet fully clear.Preeclampsia is a unique disease during pregnancy and is the main cause of perinatal maternal and neonatal death.Therefore,a correct understanding of preeclampsia and early effective prevention are of great significance for reducing the harm of preeclampsia and improving the outcome of mothers and infants.In this paper,starting from the pathogenesis of preeclampsia,the research progress of drug intervention is reviewed to provide some reference for clinical prevention of preeclampsia.关键词
子痫前期/妊娠期并发症/蛋白尿Key words
Preeclampsia/Pregnancy complications/Proteinuria分类
医药卫生引用本文复制引用
郭丽,黄淑娟,隋红梅..子痫前期的药物预防研究[J].医学信息,2023,36(23):170-173,183,5.
